A novel signature based on CeRNA and immune status predicts prognostic risk and drug sensitivity in gastric cancer patients

BACKGROUND: At present, there is increasing evidence that both competitive endogenous RNAs (ceRNAs) and immune status in the tumor microenvironment (TME) can affect the progression of gastric cancer (GC), and are closely related to the prognosis of patients. However, few studies have linked the two...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Wei, Zhou, Weiguo, Li, Mengying, Zhang, Zehua, Zhang, Xun, Yang, Kang, Yang, Shiyi, Cao, Guodong, Chen, Bo, Xiong, Maoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723231/
https://www.ncbi.nlm.nih.gov/pubmed/36483555
http://dx.doi.org/10.3389/fimmu.2022.951135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723231/
https://www.ncbi.nlm.nih.gov/pubmed/36483555
http://dx.doi.org/10.3389/fimmu.2022.951135

Ejemplares similares